- Home
- ANIK vs XBIT Comparison
ANIK vs XBIT Comparison
Compare ANIK & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- XBIT
- Stock Information
- Founded
- ANIK 1983
- XBIT 2005
- Country
- ANIK United States
- XBIT United States
- Employees
- ANIK N/A
- XBIT N/A
- Industry
- ANIK Medical/Dental Instruments
- XBIT Pharmaceuticals and Biotechnology
- Sector
- ANIK Health Care
- XBIT Health Care
- Exchange
- ANIK Nasdaq
- XBIT Nasdaq
- Market Cap
- ANIK 255.6M
- XBIT 211.9M
- IPO Year
- ANIK 1993
- XBIT 2015
- Fundamental
- Price
- ANIK $16.54
- XBIT $6.27
- Analyst Decision
- ANIK Buy
- XBIT
- Analyst Count
- ANIK 2
- XBIT 0
- Target Price
- ANIK $24.50
- XBIT N/A
- AVG Volume (30 Days)
- ANIK 95.2K
- XBIT 72.1K
- Earning Date
- ANIK 10-31-2024
- XBIT 11-13-2024
- Dividend Yield
- ANIK N/A
- XBIT N/A
- EPS Growth
- ANIK N/A
- XBIT N/A
- EPS
- ANIK N/A
- XBIT N/A
- Revenue
- ANIK $164,168,000.00
- XBIT N/A
- Revenue This Year
- ANIK N/A
- XBIT N/A
- Revenue Next Year
- ANIK N/A
- XBIT N/A
- P/E Ratio
- ANIK N/A
- XBIT N/A
- Revenue Growth
- ANIK 0.52
- XBIT N/A
- 52 Week Low
- ANIK $15.83
- XBIT $3.83
- 52 Week High
- ANIK $29.12
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- ANIK 38.75
- XBIT 42.25
- Support Level
- ANIK $15.83
- XBIT $6.06
- Resistance Level
- ANIK $18.18
- XBIT $7.24
- Average True Range (ATR)
- ANIK 0.62
- XBIT 0.51
- MACD
- ANIK 0.05
- XBIT -0.03
- Stochastic Oscillator
- ANIK 37.45
- XBIT 17.72
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.